...
首页> 外文期刊>Stem Cell Reports >Broad-Spectrum Anti-coronavirus Vaccines and Therapeutics to Combat the Current COVID-19 Pandemic and Future Coronavirus Disease Outbreaks
【24h】

Broad-Spectrum Anti-coronavirus Vaccines and Therapeutics to Combat the Current COVID-19 Pandemic and Future Coronavirus Disease Outbreaks

机译:广谱抗冠状病毒疫苗和治疗方法,用于打击当前的Covid-19大流行和未来冠状病毒疾病爆发

获取原文
           

摘要

While the COVID-19 pandemic caused by SARS-CoV-2 is continuing, it may become worse in the coming winter months with a high potential for the emergence and spread of escape variants of SARS-CoV-2. SARS-related CoVs (SARSr-CoVs) from bats may also cause outbreaks of emerging coronavirus diseases in the future. These predictions call for the development of broad-spectrum anti-coronavirus vaccines and therapeutics to combat the current COVID-19 pandemic and future emerging coronavirus disease epidemics. In this review, we describe advances and challenges in the development of broad-spectrum vaccines and neutralizing antibodies against lineage B betacoronaviruses (β-CoV-Bs), including SARS-CoV-2, SARS-CoV, and SARSr-CoVs, as well as peptide-based pan-CoV fusion inhibitors and their potential in the prevention and treatment of COVID-19 and other human coronavirus infections.
机译:虽然Covid-19由SARS-COV-2引起的大流行是持续的,但在即将到来的冬季可能会变得更糟,并且SARS-COV-2的逃生变异的出现和传播的高潜力。 来自蝙蝠的SARS相关的COV(SARSR-COV)也可能导致未来出现新兴冠状病毒疾病的爆发。 这些预测呼吁开发广谱抗冠状病毒疫苗和治疗方法,以打击当前的Covid-19大流行和未来新兴冠状病毒疾病流行病。 在本文中,我们描述了在广谱疫苗和中和谱系中和谱系B Betacoronaviruses(β-CoV-BS)的抗体的进步和挑战,以及SARS-COV-2,SARS-COV和SARSR-COVS,以及SARSR-COV 作为肽的泛COV融合抑制剂及其在预防和治疗Covid-19和其他人冠状病毒感染中的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号